ZURICH, May 29, 2025 (GLOBE NEWSWIRE) -- VERAXA Biotech AG (“VERAXA”), an emerging leader in designing novel cancer therapies and proposed de-SPAC acquisition target of Voyager Acquisition Corp.
2+ days of education, relationship-building, and uninterrupted private meetings between decision-makers and vendors focused on all aspects of hotel operations in leading hotels across the U.S. and ...
Dortmund / Fujian, November 04, 2024 – Fujian Southeast Electrochemical Co., LTD. (“SEEC”) and thyssenkrupp nucera have reached another milestone in their collaboration. The Chinese chemical company ...
2+ days of education, relationship-building, and uninterrupted private meetings between decision-makers and vendors focused on all aspects of hotel operations in leading hotels across the U.S. and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results